Trademarkia Logo

Canada

C$
LETYBO
REGISTERED

on 30 Oct 2024

Last Applicant/ Owned by

HUGEL INC.

61-20, Sinbuk-ro, Sinbuk-eupChuncheon-siGangwon-do

KR

Serial Number

1962001 filed on 9th May 2019

Registration Number

TMA1266213 registered on 30th Oct 2024

Registration expiry Date

30th Oct 2034

Correspondent Address

BORDEN LADNER GERVAIS LLP

World Exchange Plaza100 Queen Street, Suite 1300Ottawa

ONTARIO

CA

K1P1J9

LETYBO

Trademark usage description

pharmaceutical preparations for the treatment of muscle spasms; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical pr Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of muscle spasms; pharmaceutical preparations for treating dystonia; muscle relaxants; pharmaceutical preparations for animals for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely, dermatitis, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars; pharmaceutical preparations containing botulinum toxin; botulinum toxin; pharmaceutical preparations containing botulinum toxin for the treatment of wrinkles; pharmaceutical preparations containing botulinum toxin fragments for the treatment of wrinkles; pharmaceutical preparations for use in treating urogenital system diseases and conditions; bacterial toxins used for the treatment of cancer, blepharospasm, spasticity, dynamic equinus foot deformity, overactive bladder, benign masseter muscle hypertrophy, psychiatric disorders, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, depression, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis, cerebral palsy, sports injuries, namely, injured and torn skin, muscle, ligaments and bone, tremors, namely, spasmodic smooth, striated and cardiac muscles, and for the relief of pain; pharmaceutical preparations for digestive system namely, for the treatment of peptic ulcer and gastroesophageal reflux disease; pharmaceutical preparations for treatment of skin conditions, namely acne, dryness and signs of skin aging; pharmaceutical preparations for treating neurological diseases and disorders, namely, Alzheimer's, Huntington's disease, cerebral palsy, myasthenia gravis, brain injury, spinal cord injury and seizure disorders, carpal tunnel syndrome, periodic limb movement disorder, epilepsy, radiculopathy, spinal muscular atrophy; ophthalmic preparations; anti-itch ointments for pharmaceutical purposes; chemical preparations for pharmaceutical purposes for the treatment of cancer, blepharospasm, spasticity, dynamic equinus foot deformity, overactive bladder, benign masseter muscle hypertrophy, psychiatric disorders, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, depression, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis, cerebral palsy, sports injuries, namely, injured and torn skin, muscle, ligaments and bone, tremors, namely, spasmodic smooth, striated and cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; pharmaceutical agents for treatment of the upper layers of the epidermis; drugs for medical purposes for the treatment of neurological disorders, namely, cancer, blepharospasm, spasticity, dynamic equinus foot deformity, overactive bladder, benign masseter muscle hypertrophy, psychiatric disorders, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, depression, and for the treatment of muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis, cerebral palsy, sports injuries, namely, injured and torn skin, muscle, ligaments and bone, tremors, namely, spasmodic smooth, striated and cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological preparations for medical and veterinary purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; microorganisms for medical purposes namely, bacteria and fungi for the treatment of cancer, blepharospasm, spasticity, dynamic equinus foot deformity, overactive bladder, benign masseter muscle hypertrophy, psychiatric disorders, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia, depression, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhidrosis, cerebral palsy, sports injuries, namely, injured and torn skin, muscle, ligaments and bone, tremors, namely, spasmodic smooth, striated and cardiac muscles, and pain, namely, smooth muscle pain, striated muscle pain, cardiac muscle pain, neuropathic pain, inflammatory pain, visceral pain, chronic pain, acute pain, traumatic injury pain, referred pain, growing pain, hunger pain, intractable pain, labour pain, organic pain, phantom limb pain, postprandial pain, psychogenic pain, back pain, post-stroke pain, cancer pain, nociceptive pain, headache pain, prostatic pain, and bladder pain; biological tissue cultures of microorganisms for medical purposes; diagnostic chemical reagents for medical diagnostic use; pharmaceutical preparations for animals for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; adjuvants for medical purposes, namely, vaccines for human use; hyaluronic acid preparations for medical purposes for aesthetic treatments namely injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; medicines for human purposes for the treatment of aesthetic dermatology, orthopaedics, arthritis and ophthalmology; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia; pharmaceutical preparations for the treatment of orthopaedic disorders, namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis; pharmaceutical preparations for alleviating wrinkles; injectable dermal filler; pain relief medicines for dental purposes; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars; pharmaceutical preparations for treating skin disorders, namely for the treatment of bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections; pharmaceutical preparations mainly based on hyaluronic acid for aesthetic treatments namely injectable for intradermal and subcutaneous application for facial and body skin tightening and smoothing; therapeutic drugs and agents for the treatment of excessive sweating, excessive eye blinking, blepharospasm, spasmodic torticollis, hemifacial spasm, muscle cramp, dynamic equinus foot deformity, strabismus, neuropathy pain, facial wrinkles, headache, pain, dystonia, urogenital system diseases and conditions, skin disorders.


Classification kind code

12

Mark Details


Serial Number

1962001

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 23rd Sept 2024
Registration Pending
Submitted for opposition 42
on 3rd Jul 2024
Advertised
Submitted for opposition 26
on 7th Jun 2024
Approved
Submitted for opposition 27
on 7th Jun 2024
Approval Notice Sent
Submitted for opposition 22
on 29th Nov 2023
Search Recorded
Submitted for opposition 20
on 29th Nov 2023
Examiner's First Report
Submitted for opposition 287
on 13th Jun 2022
Pre-Assessment Letter Sent
Submitted for opposition 31
on 14th May 2019
Formalized
Submitted for opposition 1
on 10th May 2019
Created
Submitted for opposition 30
on 9th May 2019
Filed